Sex-and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States
A Garg, JS Kirby, J Lavian, G Lin, A Strunk - JAMA dermatology, 2017 - jamanetwork.com
Importance The true prevalence of hidradenitis suppurativa (HS) is unknown. Objective To
establish standardized overall and group-specific prevalence estimates for HS in the United …
establish standardized overall and group-specific prevalence estimates for HS in the United …
The evolving concept of SLE comorbidities
LA González, GS Alarcon - Expert review of clinical immunology, 2017 - Taylor & Francis
Introduction: The survival of SLE patients has improved significantly over the past few
decades placing them at increased risk of cardiovascular disease (CVD), malignancies, and …
decades placing them at increased risk of cardiovascular disease (CVD), malignancies, and …
Клиническое значение N-концевого фрагмента натрийуретического пептида у пациентов с системной красной волчанкой, не получающих патогенетическую …
ТА Панафидина, МА Сохова, ТВ Попкова… - Научно …, 2017 - cyberleninka.ru
Цель определить уровень N-концевого фрагмента предшественника мозгового
натрийуретического пептида В-типа (N-terminal fragment of brain natriuretic peptide …
натрийуретического пептида В-типа (N-terminal fragment of brain natriuretic peptide …
[HTML][HTML] Eventos cardiovasculares en pacientes con lupus eritematoso sistémico y su asociación con factores de riesgo cardiovascular
MI Acosta-Colmán, G Avila-Pedretti… - Memorias del Instituto …, 2017 - scielo.iics.una.py
Los pacientes con lupus eritematoso sistémico (LES) presentan un elevado riesgo
cardiovascular, cuya etiología aún no se conoce con exactitud. Se ha postulado que …
cardiovascular, cuya etiología aún no se conoce con exactitud. Se ha postulado que …
Eventos cardiovasculares en pacientes con lupus eritematoso sistémico y su asociación con factores de riesgo cardiovascular
MIA Colmán, GA Pedretti… - … del Instituto de …, 2017 - revistascientificas.una.py
Los pacientes con lupus eritematoso sistémico (LES) presentan un elevado riesgo
cardiovascular, cuya etiología aún no se conoce con exactitud. Se ha postulado que …
cardiovascular, cuya etiología aún no se conoce con exactitud. Se ha postulado que …
Cardiovascular events in patients with systemic lupus erythematosus and their association with cardiovascular risk factors
MI Acosta-Colmán, G Avila-Pedretti… - Memorias del Instituto …, 2017 - scielo.iics.una.py
ACOSTA-COLMAN, María Isabel et al. Cardiovascular events in patients with systemic lupus
erythematosus and their association with cardiovascular risk factors. Mem. Inst. Investig …
erythematosus and their association with cardiovascular risk factors. Mem. Inst. Investig …
[HTML][HTML] Cardiovascular disease risk in patients with systemic lupus erythematosus
H Fosam - Rheumatology Advisor. Published online, 2017 - rheumatologyadvisor.com
The improved treatment of systemic lupus erythematosus (SLE) with increased life
expectancy has been accompanied by a 9-to 50-fold elevated risk for developing …
expectancy has been accompanied by a 9-to 50-fold elevated risk for developing …